195 related articles for article (PubMed ID: 35775072)
21. Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes.
Cowart K; Updike W; Bullers K
Diabetes Technol Ther; 2020 May; 22(5):337-345. PubMed ID: 31859531
[No Abstract] [Full Text] [Related]
22. The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials.
De Ridder F; den Brinker M; De Block C
Ther Adv Endocrinol Metab; 2019; 10():2042018819871903. PubMed ID: 31516690
[TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring.
Edelman SV; Argento NB; Pettus J; Hirsch IB
Diabetes Care; 2018 Nov; 41(11):2265-2274. PubMed ID: 30348844
[TBL] [Abstract][Full Text] [Related]
24. Practical considerations for continuous glucose monitoring in elite athletes with type 1 diabetes mellitus: A narrative review.
Brar G; Carmody S; Lumb A; Shafik A; Bright C; Andrews RC
J Physiol; 2024 May; 602(10):2169-2177. PubMed ID: 38680058
[TBL] [Abstract][Full Text] [Related]
25. Selecting the Appropriate Continuous Glucose Monitoring System - a Practical Approach.
Adolfsson P; Parkin CG; Thomas A; Krinelke LG
Eur Endocrinol; 2018 Apr; 14(1):24-29. PubMed ID: 29922348
[TBL] [Abstract][Full Text] [Related]
26. Switching from Intermittently Scanned Continuous Glucose Monitoring to Real-Time Continuous Glucose Monitoring with a Predictive Urgent Low Soon Alert Reduces Exposure to Hypoglycemia.
Preechasuk L; Avari P; Oliver N; Reddy M
Diabetes Technol Ther; 2024 Apr; ():. PubMed ID: 38315504
[TBL] [Abstract][Full Text] [Related]
27. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
28. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
[TBL] [Abstract][Full Text] [Related]
29. Time in Range in Children with Type 1 Diabetes before and during a Diabetes Camp-A Ceiling Effect?
Nagl K; Bozic I; Berger G; Tauschmann M; Blauensteiner N; Weimann K; Mader JK; Rami-Merhar B
Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553394
[TBL] [Abstract][Full Text] [Related]
30. Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis.
Talbo MK; Katz A; Hill L; Peters TM; Yale JF; Brazeau AS
EClinicalMedicine; 2023 Aug; 62():102119. PubMed ID: 37593226
[TBL] [Abstract][Full Text] [Related]
31. A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United States.
Cowart K
J Diabetes Sci Technol; 2021 Jan; 15(1):160-166. PubMed ID: 31833388
[TBL] [Abstract][Full Text] [Related]
32. The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education.
De Ridder F; den Brinker M; De Block C
Ther Adv Endocrinol Metab; 2019; 10():2042018819865399. PubMed ID: 31384420
[TBL] [Abstract][Full Text] [Related]
33. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
[TBL] [Abstract][Full Text] [Related]
34. Study protocol: glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: the 2GO-CGM study.
Lever CS; Williman JA; Boucsein A; Watson A; Sampson RS; Sergel-Stringer OT; Keesing C; Chepulis L; Wheeler BJ; de Bock MI; Paul RG
J Diabetes Metab Disord; 2023 Dec; 22(2):1779-1792. PubMed ID: 37969919
[TBL] [Abstract][Full Text] [Related]
35. Effects of intermittently scanned continuous glucose monitoring on blood glucose control and the production of urinary ketone bodies in pregestational diabetes mellitus.
Li SY; Guo H; Zhang Y; Li P; Zhou P; Sun LR; Li J; Chen LM
Diabetol Metab Syndr; 2021 Apr; 13(1):39. PubMed ID: 33836817
[TBL] [Abstract][Full Text] [Related]
36. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol.
Zheng M; Luo Y; Lin W; Khoja A; He Q; Yang S; Zhao X; Hu P
Syst Rev; 2020 May; 9(1):120. PubMed ID: 32475343
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
38. Current status of continuous glucose monitoring among Korean children and adolescents with type 1 diabetes mellitus.
Kim JH
Ann Pediatr Endocrinol Metab; 2020 Sep; 25(3):145-151. PubMed ID: 32871645
[TBL] [Abstract][Full Text] [Related]
39. Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial.
Price DA; Deng Q; Kipnes M; Beck SE
Diabetes Ther; 2021 Jul; 12(7):2089-2099. PubMed ID: 34089138
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
